Evidence map›Paper›PMID 31804684›Full record

SynthesisJournal of travel medicine2019

Cholera in travellers: a systematic review.

Bradley A Connor, Richard Dawood, Mark S Riddle, Davidson H Hamer

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Journal of travel medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 43 citations in OpenAlex.

  1. One Swallow Does Not Make a Summer: A Confirmed Case of ImportedCase reports in infectious diseases · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The cholera challenge: How should the world respond?New microbes and new infections · 2023
    Article
  7. Article
  8. Article
  9. Vaccines and Senior Travellers.Frontiers in aging · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Bradley A ConnorWeill Cornell Medical College and the New York Center for Travel and Tropical Medicine, New York, NY, USA.
Richard DawoodFleet Street Travel Clinic, London EC4Y 1AA, UK.
Mark S RiddleUniversity of Nevada, Reno School of Medicine, Reno, NV, 89557, USA.
Davidson H HamerDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA.
Boston Medical Center · USCornell University · USUniversity of Nevada, Reno · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exposure to cholera is a risk for individuals and groups travelling to endemic areas, and the bacteria can be imported to cholera-free countries by returning travellers. This systematic review of the literature describes the circumstances in which cholera infection can occur in travellers and considers the possible value of the cholera vaccine for prevention in travellers. PubMed and EMBASE were searched for case reports of cholera or diarrhoea among travellers, with date limits of 1 January 1990-30 April 2018. Search results were screened to exclude the following articles: diarrhoea not caused by cholera, cholera in animals, intentional cholera infection in humans, non-English articles and publications on epidemics that did not report clinical details of individual cases and publications of cases pre-dating 1990. Articles were reviewed through descriptive analytic methods and information summarized. We identified 156 cases of cholera imported as a consequence of travel, and these were reviewed for type of traveller, source country, serogroup of cholera, treatment and outcomes. The case reports retrieved in the search did not report consistent levels of detail, making it difficult to synthesize data across reports and draw firm conclusions from the data. This clinical review sheds light on the paucity of actionable published data regarding the risk of cholera in travellers and identifies a number of gaps that should drive additional effort. Further information is needed to better inform evidence-based disease prevention strategies, including vaccination for travellers visiting areas of cholera risk. Modifications to current vaccination recommendations to include or exclude current or additional traveller populations may be considered as additional risk data become available. The protocol for this systematic review is registered with PROSPERO (registration number: 122797).

Indexed as

TravelCholeraCholera VaccinesHumansVaccinationCholera VaccinesCholera riskCholera vaccineSerogroup 01Serogroup O139Vibrio choleravibriocidal antibody

Identifiers

PMID31804684
PMCPMC6927393
OpenAlexW2994525095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.